BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31933763)

  • 1. Matrilin-2 is a novel prognostic marker in osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Int J Clin Exp Pathol; 2019; 12(10):3752-3760. PubMed ID: 31933763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Upregulation of PLOD2 promotes invasion and metastasis of osteosarcoma cells].
    Cao F; Kang XH; Cui YH; Wang Y; Zhao KL; Wang YN; Kou WZ; Miao ZH; Cao XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):435-440. PubMed ID: 31216829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of long non-coding RNA MALAT1 in osteosarcoma and its effect on invasiveness and metastatic potential of osteosarcoma cells].
    Zhang JH; Kang XH; Lu P; Miao ZH; Sun GS; Cao XJ; Cao F
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):561-5. PubMed ID: 27510783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
    Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
    [No Abstract]   [Full Text] [Related]  

  • 7. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
    Ju L; Zhou YM; Yang GS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.
    Cui SQ; Wang H
    Tumour Biol; 2015 Sep; 36(9):6949-58. PubMed ID: 25854173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
    Wang N; Chen Y; Wu J
    Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
    Ma X; Yang Y; Wang Y; An G; Lv G
    Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-598: A tumor suppressor with biomarker significance in osteosarcoma.
    Liu K; Sun X; Zhang Y; Liu L; Yuan Q
    Life Sci; 2017 Nov; 188():141-148. PubMed ID: 28882648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression.
    Wang J; Ni J; Song D; Ding M; Huang J; Li W; He G
    Life Sci; 2019 Oct; 234():116771. PubMed ID: 31421084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z; Zhang W; Mao J; Xu Z; Fan M
    Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
    Sun W; Wang W; Lei J; Li H; Wu Y
    Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells.
    Liu C; Han X; Li B; Huang S; Zhou Z; Wang Z; Wang W
    Cancer Manag Res; 2021; 13():6879-6889. PubMed ID: 34512027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDHB may be a significant predictor of poor prognosis in osteosarcoma.
    Li C; Chen Y; Bai P; Wang J; Liu Z; Wang T; Cai Q
    Am J Transl Res; 2016; 8(11):4831-4843. PubMed ID: 27904684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of relaxin-2 in human primary osteosarcoma.
    Ma J; Niu M; Yang W; Zang L; Xi Y
    Cancer Cell Int; 2013 Jun; 13(1):59. PubMed ID: 23758748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
    Qi XD; Xu SY; Song Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.